For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
The move comes as drug developers face mounting pressure from faster timelines and increasingly complex manufacturing processes
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
One task, one interaction, one pair, experts advocate
Enhertu recently received Breakthrough Therapy Designation, accelerating development and review for this critical patient population
Subscribe To Our Newsletter & Stay Updated
